| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2007.04.060 |
| P698 | PubMed publication ID | 17570566 |
| P50 | author | Katrin Susanne Kohl | Q65555419 |
| James J Sejvar | Q88977708 | ||
| Najwa Khuri-Bulos | Q104746256 | ||
| P2093 | author name string | Jane Gidudu | |
| Max Wiznitzer | |||
| Terhi Tapiainen | |||
| James Oleske | |||
| Jochem Galama | |||
| Roman Bilynsky | |||
| Dean Blumberg | |||
| Therese Cvetkovich | |||
| Brighton Collaboration Encephalitis Working Group | |||
| Lakshmi Katikaneni | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Surveillance for Unexplained Deaths and Critical Illnesses Due to Possibly Infectious Causes, United States, 1995-1998 | Q27489402 | ||
| Assessment of coma and impaired consciousness. A practical scale | Q29618624 | ||
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials | Q29619671 | ||
| Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data | Q31116047 | ||
| Disorders that mimic central nervous system infections | Q33750289 | ||
| Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features | Q33980439 | ||
| Cerebral vascular accidents in patients over the age of 60. II. Prognosis | Q34241339 | ||
| Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease | Q36377419 | ||
| Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains) | Q36881325 | ||
| Chlamydia pneumoniae-associated ADEM. | Q37875762 | ||
| Epidemiology of encephalitis in children. A prospective multicentre study | Q37882554 | ||
| Etiology of acute encephalitis in childhood in Slovenia. | Q37890107 | ||
| Poliomyelitis in the USA: virtual elimination of disease caused by wild virus | Q38479203 | ||
| Effect on the white cell count of contaminating cerebrospinal fluid with blood | Q38927514 | ||
| Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases | Q39251719 | ||
| Acute disseminated encephalomyelitis associated with Pasteurella multocida meningitis. | Q40558088 | ||
| Neurologic complications of Semple-type rabies vaccine: clinical and immunologic studies | Q40798628 | ||
| Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins | Q40808928 | ||
| Neurological complications to vaccination against Japanese encephalitis | Q40816725 | ||
| Acute viral encephalitis: its diagnosis and outcome | Q40854883 | ||
| Acute demyelinating disease. Classification and non-invasive diagnosis | Q41101210 | ||
| Acute encephalitis | Q41140116 | ||
| Normal Laboratory Values of CSF During Pregnancy | Q41667155 | ||
| Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination | Q41854384 | ||
| Lack of validity of standard corrections for white blood cell counts of blood-contaminated cerebrospinal fluid in infants | Q43573447 | ||
| Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Epidemiology | Q46747148 | ||
| Acute disseminated encephalomyelitis: MR imaging features | Q48098002 | ||
| Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients | Q48621181 | ||
| Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. | Q50697484 | ||
| Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. | Q52050849 | ||
| Acute disseminated encephalomyelitis | Q56038007 | ||
| Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the Vaccine Adverse Event Reporting System | Q57954188 | ||
| An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group | Q64131638 | ||
| STUDIES ON VIRAL ENCEPHALITIS | Q64384430 | ||
| Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks | Q67479450 | ||
| Distinguishing cerebrospinal fluid abnormalities in children with bacterial meningitis and traumatic lumbar puncture | Q68819562 | ||
| Determination of leukocytosis in traumatic spinal tap specimens | Q69106095 | ||
| The cytology of the normal cerebrospinal fluid | Q70441650 | ||
| The incidence and aetiology of central nervous system infections in Helsinki in 1980 | Q70532025 | ||
| PMNs in normal spinal fluid examined by the cytocentrifuge technique | Q71204569 | ||
| Cerebrospinal fluid values in the term neonate | Q71675023 | ||
| Pediatric coma scale | Q72531043 | ||
| Postictal cerebrospinal fluid abnormalities in children | Q73592023 | ||
| Acute Disseminated Encephalomyelitis | Q74582972 | ||
| The development of standardized case definitions and guidelines for adverse events following immunization | Q80074697 | ||
| Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine | Q81053225 | ||
| P433 | issue | 31 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | encephalitis | Q199615 |
| acute disseminated encephalomyelitis | Q424242 | ||
| myelitis | Q551085 | ||
| immunization | Q1415366 | ||
| immunization safety | Q105259234 | ||
| P1104 | number of pages | 22 | |
| P304 | page(s) | 5771-5792 | |
| P577 | publication date | 2007-05-11 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data | |
| P478 | volume | 25 |
| Q37343730 | A clinical approach to diagnosis of autoimmune encephalitis. |
| Q50716193 | A risk-benefit analysis of vaccination. |
| Q45997873 | Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis. |
| Q31118832 | Acute Disseminated Encephalomyelitis following Vaccination against Hepatitis B in a Child: A Case Report and Literature Review |
| Q39673099 | Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide Surveillance |
| Q61716561 | Acute disseminated encephalomyelitis |
| Q38875155 | Acute disseminated encephalomyelitis following inactivated influenza vaccination in the Brazilian Amazon: a case report |
| Q37076968 | Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler |
| Q37934056 | Acute disseminated encephalomyelitis following influenza vaccination. |
| Q37469666 | Acute disseminated encephalomyelitis following seasonal influenza vaccination in an elderly patient |
| Q54998197 | Acute disseminated encephalomyelitis in a case of autoimmune haemolytic anaemia: a rare association. |
| Q34291128 | Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine |
| Q38374044 | Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome |
| Q30832727 | Acute encephalitis in children: Progress and priorities from an Australasian perspective |
| Q35661817 | Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013 |
| Q64129682 | Adverse event reports following Japanese encephalitis vaccination in the United States, 1999–2009 |
| Q40098397 | Adverse event reports following yellow fever vaccination, 2007-13. |
| Q41701215 | Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012. |
| Q64137454 | Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016 |
| Q40206879 | Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil |
| Q38080334 | Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010. |
| Q47569535 | Algorithm to assess causality after individual adverse events following immunizations |
| Q31116047 | Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data |
| Q34460643 | Autoimmune encephalitis and its relation to infection |
| Q38029858 | Biologically plausible and evidence-based risk intervals in immunization safety research |
| Q34763755 | Brainstem encephalitis: etiologies, treatment, and predictors of outcome |
| Q57490019 | CSF neopterin, a useful biomarker in children presenting with influenza associated encephalopathy? |
| Q45977484 | Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. |
| Q55084535 | Canadian Adverse Events Following Immunization Surveillance System (CAEFISS): Annual report for vaccines administered in 2012. |
| Q28533795 | Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium |
| Q37730228 | Causality in acute encephalitis: defining aetiologies |
| Q90140950 | Central nervous system (CNS) enterovirus infections: A single center retrospective study on clinical features, diagnostic studies, and outcome |
| Q64118602 | Clinical Utilization of the FilmArray Meningitis/Encephalitis (ME) Multiplex Polymerase Chain Reaction (PCR) Assay |
| Q55044063 | Clinical characteristics and complications of rotavirus gastroenteritis in children in east London: A retrospective case-control study. |
| Q34428943 | Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial |
| Q42326202 | Cyclosporine in the treatment of a case of fulminant and refractory acute disseminated encephalomyelitis |
| Q91311303 | Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015 |
| Q57030919 | Development of standard clinical endpoints for use in dengue interventional trials |
| Q34000824 | Diagnosis and management of acute encephalitis: A practical approach |
| Q35770681 | Diphtheria, pertussis (whooping cough), and tetanus vaccine induced recurrent seizures and acute encephalopathy in a pediatric patient: Possibly due to pertussis fraction |
| Q36645032 | Enabling Precision Medicine With Digital Case Classification at the Point-of-Care. |
| Q47204012 | Encephalitis diagnosis using metagenomics: application of next generation sequencing for undiagnosed cases. |
| Q47567528 | Encephalitis in US Children |
| Q39350135 | Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination |
| Q53838027 | Epidemiological Profile of Acute Viral Encephalitis in a Sample of Egyptian Children. |
| Q51717086 | Evaluating the Brighton Collaboration case definitions, aseptic meningitis, encephalitis, myelitis, and acute disseminated encephalomyelitis, by systematic analysis of 255 clinical cases. |
| Q31103326 | Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data |
| Q38179439 | How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria? |
| Q92142515 | Immunogenicity and safety of fractional dose yellow fever vaccination: A systematic review and meta-analysis |
| Q39650695 | Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study |
| Q84893363 | Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008 |
| Q99573875 | Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study |
| Q30587338 | Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines |
| Q30392687 | Pandemic H1N1 Vaccination and Incidence of Acute Disseminated Encephalomyelitis in Manitoba |
| Q39967464 | Pilot surveillance for childhood encephalitis in Australia using the Paediatric Active Enhanced Disease Surveillance (PAEDS) network |
| Q34139149 | Post infectious CNS disorders: towards a unified approach. |
| Q40194080 | Post vaccine acute disseminated encephalomyelitis as the first manifestation of chromosome 22q11.2 deletion syndrome in a 15-month old baby: a case report |
| Q30713580 | Post-licensure rapid immunization safety monitoring program (PRISM) data characterization |
| Q33163984 | Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience |
| Q34870245 | Post-vaccination encephalomyelitis: literature review and illustrative case |
| Q94947180 | Review of pediatric encephalitis and encephalopathy cases following immunization reported to the Canadian Immunization Monitoring Program Active (IMPACT) from 1992 to 2012 |
| Q91821190 | Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine |
| Q37197620 | Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy. |
| Q36278634 | Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China |
| Q36100736 | Template protocol for clinical trials investigating vaccines--focus on safety elements |
| Q41987697 | The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance From Australia, 2013-2015. |
| Q54232538 | The neurological complications of chikungunya virus: A systematic review. |
| Q26773027 | The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper |
| Q34635624 | The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review |
| Q91227810 | Vaccination-associated acute disseminated encephalomyelitis |
| Q94028794 | Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017 |
| Q34763836 | Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine |
Search more.